NASDAQ: AGEN
Agenus Inc Earnings Dates, Reports, Calls

Agenus earnings were -$190.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AGEN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$25.3M, down 44.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AGEN reported annual earnings of -$227.4M, with -7.5% growth.

AGEN earnings history

Current Revenue
$99.5M
Current Earnings
-$190.8M
Current Profit Margin
-191.7%

AGEN Return on Equity

Insufficient data to display

AGEN undefined

Current Company
-79.7%
Current Industry
-2.5%
AGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AGEN announces earnings.

AGEN undefined

Current Company
1,106.22%
Current Industry
5.8%
AGEN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AGEN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AGEN-$76.47M-$190.81MN/A-$8.57
LYEL-$316.47M-$334.52MN/A-$25.00
ASMB-$39.46M-$39.92MN/A-$6.23
VOR-$110.07M-$118.60MN/A-$1.51
BDTX$5.44M$5.09MN/A$0.08

Agenus Earnings Reports & History FAQ

What were Agenus's earnings last quarter?

On AGEN's earnings call on Invalid Date, Agenus (NASDAQ: AGEN) reported Q1 2025 earnings per share (EPS) of -$1.03, up 66.12% year over year. Total AGEN earnings for the quarter were -$25.32 million. In the same quarter last year, Agenus's earnings per share (EPS) was -$3.04.

If you're new to stock investing, here's how to buy Agenus stock.

Is Agenus profitable or losing money?

As of the last Agenus earnings report, Agenus is currently losing money. Agenus's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$190.59 million, a 20.39% decrease year over year.

What was AGEN's earnings growth in the past year?

As of Agenus's earnings date in Invalid Date, Agenus's earnings has grown year over year. AGEN earnings in the past year totalled -$190.81 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.